QYR Market Research Global BCG Vaccine market research | Page 4

QYResearch
The global average gross margin of BCG Vaccine is in an decreasing
trend, from 71.59% in 2012 to 69.46% in 2017. With the situation of
global economy, gross margin will be in decreasing trend in the
following five years.
The type of BCG Vaccine includes Immune BCG and Therapy BCG. The
proportion of Therapy BCG in 2016 is about 92.73%.
BCG Vaccine is widely used in Hospitals and Clinics. The most
proportion of BCG Vaccine is sold in Hospitals and the market share in
2016 is about 74.14%, and the Hospitals have upstream trend.
www.qyresearch.com